Adeniyi Oyebade
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Graduate Student
Also affiliated: Adeyemi Federal University of Education, Ondo, Nigeria (2025)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Adeniyi Oyebade's research focuses on the development and application of nanomedicines for cancer therapy and antimicrobial applications. His work includes the creation of doxorubicin-based ionic nanomedicines designed for combined chemo-phototherapy and investigating the role of endocytosis pathways in their efficacy. Oyebade has also explored the use of macrocyclic histone deacetylase inhibitor-based nanomedicines for near-infrared-responsive cancer treatment. Additionally, his research encompasses the development of antibiotic-coupled therapies for enhanced bacterial killing and the targeted delivery of drugs like rapamycin via epidermal growth factor receptors for pancreatic cancer treatment. He has published nine papers, accumulating 56 citations, and holds an h-index of 4. Oyebade collaborates with researchers at the University of Arkansas at Little Rock, including Noureen Siraj, Mujeebat Bashiru, Nawab Ali, and Mavis Forson.
Metrics
- h-index: 4
- Publications: 9
- Citations: 56
Positions
-
Graduate Student 2022–presentUniversity of Arkansas at Little Rock Chemistry ORCID
Selected Publications
-
Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
-
Carbon-Based Anode Materials for Metal-Ion Batteries: Current Status, Challenges, and Future Directions (2025)
-
Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
-
Comparative Study of the Physicochemical Properties of Oil from Underutilized Seeds of Citrus Paradisi, Citrus Lemon and Citrus Sinensis (2025)
-
IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024)
-
Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024)
-
Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods (2024)
-
Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024)
-
Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria (2023)
Collaboration Network
Top Collaborators
- Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods
- Carbon-Based Anode Materials for Metal-Ion Batteries: Current Status, Challenges, and Future Directions
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
Showing 5 of 8 shared publications
- Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Showing 5 of 6 shared publications
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods
Similar Researchers
Based on overlapping research topics